Glenmede Trust’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Glenmede Trust's ACLS Position: Q2 2026 in Review
Glenmede Trust sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 2,640 shares — an estimated $246K sold.
Glenmede Trust first reported a position in ACLS in Q2 2013 and held it in 21 quarters. The position peaked at $1.31M in Q3 2023. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Glenmede Trust reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
- Glenmede Trust sold 2,640 Axcelis shares in Q2 2026, an estimated $246K.
- Glenmede Trust first reported a position in Axcelis in Q2 2013 and held it in 21 quarters.
- Glenmede Trust's Axcelis position peaked at $1.31M in Q3 2023.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.